Real-life use of apremilast for the treatment of psoriasis in patients with oncological comorbidities: a retrospective descriptive multicentre study in France.

Background: Systemic treatment options for psoriasis are limited for patients with recent neoplasia.

Objectives: We report the real-life use of apremilast (APR) in patients with psoriasis and recent cancer.

Materials & Methods: We conducted a retrospective, multicentre study in five hospitals and among 120 private dermatologists in the north of France from January 2015 to May 2021.

[Stevens-Johnson syndrome due to lymecycline].

Background: Reports of severe drug-induced bullous reactions to tetracyclines are rare. A case of Stevens-Johnson syndrome in a patient treated with lymecycline is reported herein.

Case Report: A 22 year-old woman with acne was referred for Stevens-Johnson syndrome occurring ten days after starting lymecycline.

[Palliative care management of patients in a dermatology department].

Background: The number of patients referred to French University dermatology departments for skin cancers has increased continuously for many years. The aim of this study was to assess the management and number of patients who died in our dermatology department over a 10-year period.

Patients And Methods: All cases of patients who died in our dermatology department from 1992 to 2002 were retrospectively assessed.

[Rituximab treatment for immune thrombocytopenia associated with systemic lupus erythematosus].

Background: Immune thrombocytopenic purpura is an autoimmune disorder occasionally associated with systemic lupus erythematosus for which oral corticosteroids constitute the first-line treatment. Therapy may be complex, particularly in the event of a contraindication to the standard treatment, namely corticosteroids, splenectomy or immunosuppressants. We report the case of a patient with systemic lupus associated with immune thrombocytopenic purpura and multisystem tuberculosis.